Basilea Pharmaceutica Ltd

BSLN

Company Profile

  • Business description

    Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

  • Contact

    Hegenheimermattweg 167b
    Allschwil4123
    CHE

    T: +41 616061111

    E: [email protected]

    https://www.basilea.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    180

Stocks News & Analysis

stocks

Eagers international foray

Our view on CanadaOne acquisition.
stocks

Tesla: Shares down despite record deliveries

We think the positive third-quarter numbers will be largely offset by a weak fourth quarter.
stocks

ASX listed share dominates their industry

Shares are currently fairly valued with a Wide Moat rating.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,288.1053.600.58%
CAC 408,081.5424.910.31%
DAX 4024,378.8043.76-0.18%
Dow JONES (US)46,803.51283.790.61%
FTSE 1009,491.2563.520.67%
HKSE27,140.92146.20-0.54%
NASDAQ22,785.1758.88-0.26%
Nikkei 22545,769.50832.771.85%
NZX 50 Index13,514.0962.330.46%
S&P 5006,720.344.990.07%
S&P/ASX 2008,987.4050.800.57%
SSE Composite Index3,882.7820.250.52%

Market Movers